NPI: 1588822688 · PORTAGE, IN 46368 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/27/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 05/27/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,161 | $151K |
| 2019 | 8,281 | $155K |
| 2020 | 10,471 | $106K |
| 2021 | 5,917 | $82K |
| 2022 | 9,748 | $200K |
| 2023 | 6,709 | $166K |
| 2024 | 1,253 | $92K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,653 | 1,734 | $944K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 10,539 | 445 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 234 | 97 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 1,869 | 316 | $874.96 |
| 85041 | 1,044 | 602 | $105.98 | |
| 85048 | 1,011 | 577 | $105.06 | |
| A4657 | Syringe, with or without needle, each | 3,471 | 916 | $31.37 |
| J1270 | Injection, doxercalciferol, 1 mcg | 999 | 63 | $19.68 |
| 83970 | 401 | 224 | $18.47 | |
| 85045 | 694 | 407 | $16.26 | |
| 82728 | 511 | 277 | $10.84 | |
| 83550 | 443 | 239 | $5.24 | |
| 83540 | 476 | 252 | $3.89 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 78 | 25 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 94 | 37 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 23 | 12 | $0.00 |